Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000827503 | SCV000969154 | likely benign | not provided | 2018-05-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002067456 | SCV002470615 | likely benign | Adams-Oliver syndrome 5 | 2024-02-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002067456 | SCV002553882 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271055 | SCV002553883 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363182 | SCV002658186 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-06-18 | criteria provided, single submitter | clinical testing | The c.6223G>A (p.E2075K) alteration is located in exon 34 (coding exon 34) of the NOTCH1 gene. This alteration results from a G to A substitution at nucleotide position 6223, causing the glutamic acid (E) at amino acid position 2075 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |